Antithrombotic therapy in atrial fibrillation.
D001281:Atrial Fibrillation / Q000150:complications*; D001282:Atrial Flutter / Q000150:complications; D009202:Cardiomyopathies / Q000150:complications; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D004554:Electric Countershock / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006330:Heart Defects, Congenital / Q000150:complications; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D006980:Hyperthyroidism / Q000150:complications; D013610:Tachycardia / Q000150:complications; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents